175 related articles for article (PubMed ID: 36149017)
21. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
[TBL] [Abstract][Full Text] [Related]
22. Sinonasal undifferentiated carcinoma: current trends in treatment.
Pitman KT; Costantino PD; Lassen LF
Skull Base Surg; 1995; 5(4):269-72. PubMed ID: 17170968
[TBL] [Abstract][Full Text] [Related]
23. Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.
Johnson SB; Prisciandaro JI; Zhou J; Hadley SW; Reynolds RK; Jolly S
J Appl Clin Med Phys; 2014 Jan; 15(1):4520. PubMed ID: 24423851
[TBL] [Abstract][Full Text] [Related]
24. A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases.
Sienna J; Nguyen NT; Arsenault J; Hodson I; Meyers B
Cureus; 2018 Mar; 10(3):e2320. PubMed ID: 29755916
[TBL] [Abstract][Full Text] [Related]
25. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
26. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
27. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.
Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE
Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605
[TBL] [Abstract][Full Text] [Related]
28. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation.
London NR; Mohyeldin A; Daoud G; Gamez ME; Blakaj D; Bonomi M; Prevedello DM; Carrau RL
Head Neck; 2020 Nov; 42(11):3197-3205. PubMed ID: 32681692
[TBL] [Abstract][Full Text] [Related]
29. Non-Epstein-Barr Virus Sinonasal Undifferentiated Carcinoma Presenting as Diplopia and Rhinorrhea.
Kaifee SQ; Haq Y; Sadhar B
Cureus; 2024 Jan; 16(1):e53185. PubMed ID: 38298304
[TBL] [Abstract][Full Text] [Related]
30. Liver metastases from maxillary sinus sinonasal undifferentiated carcinoma: A case report.
D'Aguanno V; Ralli M; Cerbelli B; Greco A; De Vincentiis M
Oncol Lett; 2019 Jun; 17(6):5811-5814. PubMed ID: 31186808
[TBL] [Abstract][Full Text] [Related]
31. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
[TBL] [Abstract][Full Text] [Related]
32. Ophthalmic manifestations of an undifferentiated sinonasal carcinoma.
Wallace S; Pilon A; Kwok P; Messner LV; Hitchcock Y
Optom Vis Sci; 2008 Apr; 85(4):226-9. PubMed ID: 18382333
[TBL] [Abstract][Full Text] [Related]
33. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
[TBL] [Abstract][Full Text] [Related]
34. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival.
Lehrich BM; Goshtasbi K; Abiri A; Yasaka T; Sahyouni R; Papagiannopoulos P; Tajudeen BA; Kuan EC
Int Forum Allergy Rhinol; 2020 May; 10(5):679-688. PubMed ID: 32104985
[TBL] [Abstract][Full Text] [Related]
35. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.
Jeng YM; Sung MT; Fang CL; Huang HY; Mao TL; Cheng W; Hsiao CH
Am J Surg Pathol; 2002 Mar; 26(3):371-6. PubMed ID: 11859210
[TBL] [Abstract][Full Text] [Related]
36. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
[TBL] [Abstract][Full Text] [Related]
37. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma.
Rischin D; Porceddu S; Peters L; Martin J; Corry J; Weih L
Head Neck; 2004 May; 26(5):435-41. PubMed ID: 15122660
[TBL] [Abstract][Full Text] [Related]
38. Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
[TBL] [Abstract][Full Text] [Related]
39. The combination of volumetric arc radiation therapy and boost high-dose rate interstitial brachytherapy for T3N2c tongue cancer: a technical report.
Murakami N; Sakuramachi M; Kashihara T; Chiba T; Nakamura S; Ono K; Ueno T; Yoshimoto S; Yoshida K; Masui K; Akiyama H; Igaki H
Jpn J Clin Oncol; 2023 Jan; 53(1):85-90. PubMed ID: 36239100
[TBL] [Abstract][Full Text] [Related]
40. Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma.
Uchimoto Y; Shimamoto H; Takeshita A; Oya K; Kishino M; Fukuda Y; Toyosawa S; Oda M; Ogawa K; Kreiborg S; Mallya SM; Murakami S
J Contemp Brachytherapy; 2022 Jun; 14(3):268-272. PubMed ID: 36199998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]